PREMIER BIOMEDICAL INC - FORM 10-K - EX-32.2 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - May 15, 2020

Attached files

file filename
EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - PREMIER BIOMEDICAL INCbiei_ex321.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - PREMIER BIOMEDICAL INCbiei_ex312.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - PREMIER BIOMEDICAL INCbiei_ex311.htm
EX-4.11 - DESCRIPTION OF SECURITIES - PREMIER BIOMEDICAL INCbiei_ex411.htm
10-K - ANNUAL REPORT - PREMIER BIOMEDICAL INCbiei_10k.htm
 
EXHIBIT 32.2
 
CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
 OF THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with the Annual Report of Premier Biomedical, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Heidi H. Carl, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)           
The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)           
Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Dated: May 15, 2020
/s/ Heidi H. Carl
 
By: Heidi H. Carl
 
Its: Chief Financial Officer
 
 
A signed original of this written statement required by Section 906 has been provided to Premier Biomedical, Inc. and will be retained by Premier Biomedical, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
 

PREMIER BIOMEDICAL INC Reports